Loading…
Loading…
EQUITY / NASDAQ · XNCM
Genenta Science S.p.A. Sponsored ADR
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · EUR · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.745 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.745 USD · Volume 60,493
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Operating profit | -6,603,740 EUR | -9,764,310 EUR | — |
| Net income | -6,529,827 EUR | -8,912,495 EUR | — |
| Operating cash flow | -6,867,959 EUR | -6,240,174 EUR | — |
| Cash and cash equivalents | 5,527,672 EUR | 4,581,749 EUR | +20.65% |
| Total equity | 21,840,640 EUR | 12,495,706 EUR | +74.79% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · EUR | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · EUR | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · EUR |
|---|---|---|---|
| Capital expendituresCash flow statement | 7,625 EUR | 4,468 EUR | 13,791 EUR |
| Cash and cash equivalentsBalance sheet | 5,527,672 EUR | 4,581,749 EUR | 3,691,420 EUR |
| Financing cash flowCash flow statement | 22,287,458 EUR | 270,885 EUR | 531 EUR |
| Investing cash flowCash flow statement | -14,543,936 EUR | 6,883,064 EUR | -14,892,666 EUR |
| Net incomeIncome statement | -6,529,827 EUR | -8,912,495 EUR | -11,645,455 EUR |
| Operating cash flowCash flow statement | -6,867,959 EUR | -6,240,174 EUR | -11,205,023 EUR |
| Operating profitIncome statement | -6,603,740 EUR | -9,764,310 EUR | -11,732,942 EUR |
| Total assetsBalance sheet | 31,889,310 EUR | 14,823,993 EUR | 22,347,145 EUR |
| Total equityBalance sheet | 21,840,640 EUR | 12,495,706 EUR | 20,432,257 EUR |
| Report source | Open report ↗ Published: 04/01/2026 | Open report ↗ Published: 04/01/2026 | Open report ↗ Published: 04/01/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.